WO2001046412A3 - Interaktionsprotein für stat transkriptionsfaktor - Google Patents
Interaktionsprotein für stat transkriptionsfaktor Download PDFInfo
- Publication number
- WO2001046412A3 WO2001046412A3 PCT/DE2000/004557 DE0004557W WO0146412A3 WO 2001046412 A3 WO2001046412 A3 WO 2001046412A3 DE 0004557 W DE0004557 W DE 0004557W WO 0146412 A3 WO0146412 A3 WO 0146412A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- amino acid
- transcription factor
- relates
- stat transcription
- interaction
- Prior art date
Links
- 230000003993 interaction Effects 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102000040945 Transcription factor Human genes 0.000 title 1
- 108091023040 Transcription factor Proteins 0.000 title 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
- 102000004495 STAT3 Transcription Factor Human genes 0.000 abstract 1
- 108010017324 STAT3 Transcription Factor Proteins 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Die Erfindung betrifft isolierte Polypeptide, die als Interaktionsprotein des STAT Transkriptionsfaktors STAT3 fungieren und die entweder die im Sequenzprotokoll SEQ ID NO: 2 dargestellte oder eine durch Aminosäuresubstitution, -deletion, -insertion, oder -inversion als Allel oder Derivat daraus entstandene Aminosaüresequenz aufweisen. Sie betrifft ferner isolierte Nukleinsäuren, die solche Interaktionsproteine oder zumindest Teile davon kodieren, die Verwendung solcher Polypeptide und Nukleinsäuren für nachweisende, insbesondere diagnostische, therapeutische und Forschungszwecke und sie betrifft Reagenzien, die unter Verwendung wenigstens eines dieser Moleküle hergestellt sind, insbesondere rekombinante Vektormoleküle und Antikörper.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU33593/01A AU3359301A (en) | 1999-12-21 | 2000-12-19 | Interaction proteins for the stat transcription factor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19961899.2 | 1999-12-21 | ||
DE1999161899 DE19961899A1 (de) | 1999-12-21 | 1999-12-21 | Interaktikonsproteine für STAT Transkriptionsfaktor |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001046412A2 WO2001046412A2 (de) | 2001-06-28 |
WO2001046412A3 true WO2001046412A3 (de) | 2002-03-14 |
Family
ID=7933731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2000/004557 WO2001046412A2 (de) | 1999-12-21 | 2000-12-19 | Interaktionsprotein für stat transkriptionsfaktor |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU3359301A (de) |
DE (1) | DE19961899A1 (de) |
WO (1) | WO2001046412A2 (de) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998030688A1 (fr) * | 1997-01-10 | 1998-07-16 | Tadamitsu Kishimoto | Nouvelle proteine de regulation de la fonction stat |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1066411A4 (de) * | 1998-03-27 | 2004-09-22 | Univ Temple | Verfahren zur krebsprognose und zum screening antiproliferierender wirkstoffe |
-
1999
- 1999-12-21 DE DE1999161899 patent/DE19961899A1/de not_active Withdrawn
-
2000
- 2000-12-19 WO PCT/DE2000/004557 patent/WO2001046412A2/de active Application Filing
- 2000-12-19 AU AU33593/01A patent/AU3359301A/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998030688A1 (fr) * | 1997-01-10 | 1998-07-16 | Tadamitsu Kishimoto | Nouvelle proteine de regulation de la fonction stat |
EP0989186A1 (de) * | 1997-01-10 | 2000-03-29 | Kishimoto, Tadami | Neues protein, welches die funktion von stat reguliert |
Non-Patent Citations (5)
Title |
---|
CHIEN C-T ET AL: "THE TWO-HYBRID SYSTEM: A METHOD TO IDENTIFY AND CLONE GENES FOR PROTEINS THAT INTERACT WITH A PROTEIN OF INTEREST", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 88, 1 November 1991 (1991-11-01), pages 9578 - 9582, XP000647704, ISSN: 0027-8424 * |
FRANK DAVID A: "STAT signaling in the pathogenesis and treatment of cancer.", MOLECULAR MEDICINE (NEW YORK), vol. 5, no. 7, July 1999 (1999-07-01), pages 432 - 456, XP001021603, ISSN: 1076-1551 * |
GABLER ANGELIKA ET AL: "C102: A novel STAT3 interacting protein.", BLOOD, vol. 96, no. 11 Part 1, 16 November 2000 (2000-11-16), 42nd Annual Meeting of the American Society of Hematology;San Francisco, California, USA; December 01-05, 2000, pages 94a, XP001025916, ISSN: 0006-4971 * |
NAKA T ET AL: "NEGATIVE REGULATION OF CYTOKINE SIGNALING: STAT-INDUCED STAT INHIBITOR", TIBS TRENDS IN BIOCHEMICAL SCIENCES, ELSEVIER PUBLICATION, CAMBRIDGE, EN, vol. 24, no. 10, October 1999 (1999-10-01), pages 394 - 398, XP001019044, ISSN: 0968-0004 * |
NAKA T ET AL: "Structure and function of a new STAT-induced STAT inhibitor", NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, vol. 387, no. 6636, 26 June 1997 (1997-06-26), pages 924 - 929, XP002088455, ISSN: 0028-0836 * |
Also Published As
Publication number | Publication date |
---|---|
DE19961899A1 (de) | 2001-07-12 |
AU3359301A (en) | 2001-07-03 |
WO2001046412A2 (de) | 2001-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999066025A3 (en) | Mtbx protein and nucleic acid molecules and uses therefor | |
BR0015137A (pt) | Peptìdeos antigênicos de neisseria | |
WO1999055868A3 (en) | Fizz proteins | |
EA199800046A1 (ru) | Полипептид, последовательность днк, вакцинная композиция (варианты), антитело или его фрагмент, вакцина, применения указанных полипептида, последовательности днк и антитела или его фрагмента | |
ATE380867T1 (de) | Lactoferrinrezeptorgen von moraxella | |
EP1009752A4 (de) | Neue moleküle aus der familieder tango-77-ähnlichen proteine und ihre verewendungen. | |
AU3217100A (en) | Methods of use of a novel lysyl oxidase-related protein | |
WO2000052047A3 (en) | Human dickkopf-related protein and nucleic acid molecules and uses therefor | |
WO2000019988A8 (en) | NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF | |
AU6517400A (en) | 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof | |
WO2001061005A3 (en) | Molecules of the pyrin domain protein family and uses thereof | |
WO2000012544A3 (en) | Novel irap-bp polypeptide and nucleic acid molecules and uses therefor | |
WO1995008628A3 (en) | Nucleic acids encoding merosin, merosin fragments and uses thereof | |
WO2002061049A3 (en) | Novel molecules of the pyrin/nbs/lrr protein family and uses thereof | |
WO1999054437A3 (en) | Novel molecules of the t125-related protein family and uses thereof | |
WO2000008045A3 (en) | Novel molecules of the tango-93-related protein family and uses thereof | |
WO2001046412A3 (de) | Interaktionsprotein für stat transkriptionsfaktor | |
WO2003029434A3 (en) | Novel molecules of the hkid-1-related protein family and uses thereof | |
WO2001049714A3 (en) | Nope polypeptides, encoding nucleic acids and methods of use | |
WO2000018890A3 (en) | Protein phosphatase molecules and uses therefor | |
WO2003020912A3 (en) | Novel clark protein and nucleic acid molecules and uses therefor | |
WO1999062943A3 (en) | Novel molecules of the aip-related protein family and uses thereof | |
WO2000018923A3 (en) | Slgp protein and nucleic acid molecule and uses therefor | |
WO2000055192A3 (de) | Hämocyanin und dafür kodierende nukleinsäuresequenz | |
WO2001083753A3 (en) | Molecules of the nbs/lrr protein family and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA CN IL JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA CN IL JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |